Evidence map›Paper›PMID 30094532›Full record

ReviewHeart failure reviews2018

Transcatheter aortic valve replacement in patients with severe aortic stenosis and heart failure.

Chirag Bavishi, Dhaval Kolte, Paul C Gordon, J Dawn Abbott

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chirag BavishiDepartment of Medicine, Division of Cardiology Rhode Island Hospital, Warren Alpert Medical School of Brown University, 593 Eddy St, RIH APC814, Providence, RI, 02903, USA.ORCID http://orcid.org/0000-0001-6405-1606
Dhaval KolteDepartment of Medicine, Division of Cardiology Rhode Island Hospital, Warren Alpert Medical School of Brown University, 593 Eddy St, RIH APC814, Providence, RI, 02903, USA.
Paul C GordonDepartment of Medicine, Division of Cardiology Rhode Island Hospital, Warren Alpert Medical School of Brown University, 593 Eddy St, RIH APC814, Providence, RI, 02903, USA.
J Dawn AbbottDepartment of Medicine, Division of Cardiology Rhode Island Hospital, Warren Alpert Medical School of Brown University, 593 Eddy St, RIH APC814, Providence, RI, 02903, USA. JAbbott@Lifespan.org.
Brown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe aortic stenosis (AS) and heart failure (HF) represent an important and high-risk group of patients who are often referred for transcatheter aortic valve replacement (TAVR) due to high risk for surgical intervention. Thus far, randomized controlled trials have shown comparable outcomes between TAVR and surgical aortic valve replacement in patients with severe AS and heart failure with reduced ejection fraction. In the current review, we will discuss (1) the pathophysiology of HF in patients with severe AS, (2) role of imaging modalities in management, (3) role of biomarkers of HF on prognosis, (4) impact of other valvular heart diseases, (5) evidence from the contemporary trials on the role of TAVR in patients with severe AS and HF, and (6) future directions and research.

Indexed as

Aortic ValveAortic Valve StenosisHeart FailureHumansSeverity of Illness IndexTranscatheter Aortic Valve ReplacementTreatment OutcomeAortic stenosisHeart failureValvular heart disease

Identifiers

PMID30094532
OpenAlexW2887287477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.